{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:20:13Z","timestamp":1783408813858,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_150531"],"award-info":[{"award-number":["PP00P3_150531"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_150531"],"award-info":[{"award-number":["PP00P3_150531"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_150531"],"award-info":[{"award-number":["PP00P3_150531"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_150531"],"award-info":[{"award-number":["PP00P3_150531"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_150531"],"award-info":[{"award-number":["PP00P3_150531"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_150531"],"award-info":[{"award-number":["PP00P3_150531"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_150531"],"award-info":[{"award-number":["PP00P3_150531"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PP00P3_150531"],"award-info":[{"award-number":["PP00P3_150531"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41430-026-01750-1","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T12:44:36Z","timestamp":1776516276000},"page":"700-707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trimethylamine N-oxide (TMAO) as a prognostic marker among patients at nutritional risk. A secondary analysis of the randomized clinical trial EFFORT"],"prefix":"10.1038","volume":"80","author":[{"given":"Adina","family":"Stern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1720-6462","authenticated-orcid":false,"given":"Carla","family":"Wunderle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Tribolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8682-9578","authenticated-orcid":false,"given":"Peter J.","family":"Neyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno","family":"Stanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6400-4949","authenticated-orcid":false,"given":"Philipp","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"1750_CR1","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.nut.2015.06.007","volume":"31","author":"S Felder","year":"2015","unstructured":"Felder S, Lechtenboehmer C, Bally M, Fehr R, Deiss M, Faessler L, et al. Association of nutritional risk and adverse medical outcomes across different medical inpatient populations. Nutr (Burbank, Los Angeles Cty, Calif). 2015;31:1385\u201393. https:\/\/doi.org\/10.1016\/j.nut.2015.06.007.","journal-title":"Nutr (Burbank, Los Angeles Cty, Calif)"},{"key":"1750_CR2","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(21)01451-3","volume":"398","author":"P Schuetz","year":"2021","unstructured":"Schuetz P, Seres D, Lobo DN, Gomes F, Kaegi-Braun N, Stanga Z. Management of disease-related malnutrition for patients being treated in hospital. Lancet. 2021;398:1927\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(21)01451-3.","journal-title":"Lancet"},{"key":"1750_CR3","doi-asserted-by":"publisher","first-page":"e1915138","DOI":"10.1001\/jamanetworkopen.2019.15138","volume":"2","author":"F Gomes","year":"2019","unstructured":"Gomes F, Baumgartner A, Bounoure L, Bally M, Deutz NE, Greenwald JL, et al. Association of nutritional support with clinical outcomes among medical inpatients who are malnourished or at nutritional risk: an updated systematic review and meta-analysis. JAMA Netw Open. 2019;2:e1915138. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.15138.","journal-title":"JAMA Netw Open"},{"key":"1750_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.clnu.2015.12.010","volume":"35","author":"NE Deutz","year":"2016","unstructured":"Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, et al. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr. 2016;35:18\u201326. https:\/\/doi.org\/10.1016\/j.clnu.2015.12.010.","journal-title":"Clin Nutr"},{"key":"1750_CR5","doi-asserted-by":"publisher","unstructured":"Schuetz P, Fehr R, Baechli V, Geiser M, Gomes F, Kutz A et al. Design and rationale of the effect of early nutritional therapy on frailty, functional outcomes and recovery of malnourished medical inpatients trial (EFFORT): a pragmatic, multicenter, randomized-controlled trial. Int J Clin Trials. 2018;5. https:\/\/doi.org\/10.18203\/2349-3259.ijct20182085","DOI":"10.18203\/2349-3259.ijct20182085"},{"key":"1750_CR6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.clnu.2023.03.013","volume":"42","author":"P Schuetz","year":"2023","unstructured":"Schuetz P. Changing the malnutrition paradigm through large clinical trials. Clin Nutr. 2023;42:1237\u20138. https:\/\/doi.org\/10.1016\/j.clnu.2023.03.013.","journal-title":"Clin Nutr"},{"key":"1750_CR7","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.chest.2024.02.021","volume":"165","author":"P Schuetz","year":"2024","unstructured":"Schuetz P. More EFFORT is needed to understand how to individualize optimal protein targets to the needs of patients who are critically Ill. Chest. 2024;165:1280\u20131. https:\/\/doi.org\/10.1016\/j.chest.2024.02.021.","journal-title":"Chest"},{"key":"1750_CR8","doi-asserted-by":"publisher","first-page":"w13957","DOI":"10.4414\/smw.2014.13957","volume":"144","author":"P Schutz","year":"2014","unstructured":"Schutz P, Bally M, Stanga Z, Keller U. Loss of appetite in acutely ill medical inpatients: physiological response or therapeutic target?. Swiss Med Wkly. 2014;144:w13957. https:\/\/doi.org\/10.4414\/smw.2014.13957.","journal-title":"Swiss Med Wkly"},{"key":"1750_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57\u201363. https:\/\/doi.org\/10.1038\/nature09922.","journal-title":"Nature"},{"key":"1750_CR10","doi-asserted-by":"publisher","unstructured":"Velasquez MT, Ramezani A, Manal A, Raj DS Trimethylamine N-oxide: the good, the bad and the unknown. Toxins (Basel). 2016;8. https:\/\/doi.org\/10.3390\/toxins8110326","DOI":"10.3390\/toxins8110326"},{"key":"1750_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11739-020-02470-5","volume":"16","author":"L Guasti","year":"2021","unstructured":"Guasti L, Galliazzo S, Molaro M, Visconti E, Pennella B, Gaudio GV, et al. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis. Intern Emerg Med. 2021;16:201\u20137. https:\/\/doi.org\/10.1007\/s11739-020-02470-5.","journal-title":"Intern Emerg Med"},{"key":"1750_CR12","doi-asserted-by":"publisher","first-page":"e37825","DOI":"10.1097\/md.0000000000037825","volume":"103","author":"QA Khan","year":"2024","unstructured":"Khan QA, Asad M, Ali AH, Farrukh AM, Naseem U, Semakieh B, et al. Gut microbiota metabolites and risk of major adverse cardiovascular events and death: a systematic review and meta-analysis. Med (Balt). 2024;103:e37825. https:\/\/doi.org\/10.1097\/md.0000000000037825.","journal-title":"Med (Balt)"},{"key":"1750_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/QCO.0b013e32835d0bec","volume":"26","author":"P Schuetz","year":"2013","unstructured":"Schuetz P, Litke A, Albrich WC, Mueller B. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis. 2013;26:159\u201367. https:\/\/doi.org\/10.1097\/QCO.0b013e32835d0bec.","journal-title":"Curr Opin Infect Dis"},{"key":"1750_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2215542","volume":"55","author":"Y Li","year":"2023","unstructured":"Li Y, Lu H, Guo J, Zhang M, Zheng H, Liu Y, et al. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis. Ann Med. 2023;55:2215542. https:\/\/doi.org\/10.1080\/07853890.2023.2215542.","journal-title":"Ann Med"},{"key":"1750_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/obr.12843","volume":"20","author":"R Zhuang","year":"2019","unstructured":"Zhuang R, Ge X, Han L, Yu P, Gong X, Meng Q, et al. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: a systematic review and dose-response meta-analysis. Obes Rev. 2019;20:883\u201394. https:\/\/doi.org\/10.1111\/obr.12843.","journal-title":"Obes Rev"},{"key":"1750_CR16","doi-asserted-by":"publisher","first-page":"e36784","DOI":"10.1097\/md.0000000000036784","volume":"103","author":"JM Han","year":"2024","unstructured":"Han JM, Guo L, Chen XH, Xie Q, Song XY, Ma YL. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: a meta-analysis and dose-response relationship analysis. Med (Balt). 2024;103:e36784. https:\/\/doi.org\/10.1097\/md.0000000000036784.","journal-title":"Med (Balt)"},{"key":"1750_CR17","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/S0140-6736(18)32776-4","volume":"393","author":"P Schuetz","year":"2019","unstructured":"Schuetz P, Fehr R, Baechli V, Geiser M, Deiss M, Gomes F, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019;393:2312\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(18)32776-4.","journal-title":"Lancet"},{"key":"1750_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s0261-5614(02)00214-5","volume":"22","author":"J Kondrup","year":"2003","unstructured":"Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad Hoc EWG. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22:321\u201336. https:\/\/doi.org\/10.1016\/s0261-5614(02)00214-5.","journal-title":"Clin Nutr"},{"key":"1750_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jchromb.2015.12.002","volume":"1008","author":"C Steuer","year":"2016","unstructured":"Steuer C, Schutz P, Bernasconi L, Huber AR. Simultaneous determination of phosphatidylcholine-derived quaternary ammonium compounds by a LC-MS\/MS method in human blood plasma, serum and urine samples. J Chromatogr B Anal Technol Biomed Life Sci. 2016;1008:206\u201311. https:\/\/doi.org\/10.1016\/j.jchromb.2015.12.002.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"1750_CR20","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/advances\/nmab010","volume":"12","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Guo M, Fang X, Teng F, Tan X, Li X, et al. Gut microbiota-derived trimethylamine N-oxide and kidney function: a systematic review and meta-analysis. Adv Nutr. 2021;12:1286\u2013304. https:\/\/doi.org\/10.1093\/advances\/nmab010.","journal-title":"Adv Nutr"},{"key":"1750_CR21","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New Creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737\u201349. https:\/\/doi.org\/10.1056\/NEJMoa2102953.","journal-title":"N Engl J Med"},{"key":"1750_CR22","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575\u201384. https:\/\/doi.org\/10.1056\/NEJMoa1109400.","journal-title":"N Engl J Med"},{"key":"1750_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576\u201385. https:\/\/doi.org\/10.1038\/nm.3145.","journal-title":"Nat Med"},{"key":"1750_CR24","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","volume":"66","author":"Y-J Cheng","year":"2015","unstructured":"Cheng Y-J, Nie X-Y, Chen X-M, Lin X-X, Tang K, Zeng W-T, et al. The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk. J Am Coll Cardiol. 2015;66:2173\u201384. https:\/\/doi.org\/10.1016\/j.jacc.2015.09.029.","journal-title":"J Am Coll Cardiol"},{"key":"1750_CR25","doi-asserted-by":"publisher","unstructured":"Senthong V, Wang Z, Li XS, Fan Y, Wu Y, Tang WH et al. Intestinal microbiota-generated metabolite trimethylamine-N-oxide and 5-year mortality risk in stable coronary artery disease: the contributory role of intestinal microbiota in a COURAGE-like patient cohort. J Am Heart Assoc. 2016;5. https:\/\/doi.org\/10.1161\/jaha.115.002816","DOI":"10.1161\/jaha.115.002816"},{"key":"1750_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/circresaha.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116:448\u201355. https:\/\/doi.org\/10.1161\/circresaha.116.305360.","journal-title":"Circ Res"},{"key":"1750_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12872-019-01310-5","volume":"20","author":"ME Yao","year":"2020","unstructured":"Yao ME, Liao PD, Zhao XJ, Wang L. Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis. BMC Cardiovasc Disord. 2020;20:7. https:\/\/doi.org\/10.1186\/s12872-019-01310-5.","journal-title":"BMC Cardiovasc Disord"},{"key":"1750_CR28","doi-asserted-by":"publisher","first-page":"e2213242","DOI":"10.1001\/jamanetworkopen.2022.13242","volume":"5","author":"AM Fretts","year":"2022","unstructured":"Fretts AM, Hazen SL, Jensen P, Budoff M, Sitlani CM, Wang M, et al. Association of trimethylamine N-oxide and metabolites with mortality in older adults. JAMA Netw Open. 2022;5:e2213242. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.13242.","journal-title":"JAMA Netw Open"},{"key":"1750_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.nut.2017.07.001","volume":"45","author":"M Ottiger","year":"2018","unstructured":"Ottiger M, Nickler M, Steuer C, Bernasconi L, Huber A, Christ-Crain M, et al. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease. Nutr (Burbank, Los Angeles Cty, Calif). 2018;45:135\u2013141.e131. https:\/\/doi.org\/10.1016\/j.nut.2017.07.001.","journal-title":"Nutr (Burbank, Los Angeles Cty, Calif)"},{"key":"1750_CR30","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","volume":"38","author":"GG Schiattarella","year":"2017","unstructured":"Schiattarella GG, Sannino A, Toscano E, Giugliano G, Gargiulo G, Franzone A, et al. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis. Eur Heart J. 2017;38:2948\u201356. https:\/\/doi.org\/10.1093\/eurheartj\/ehx342.","journal-title":"Eur Heart J"},{"key":"1750_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1515\/cclm-2020-0159","volume":"59","author":"SR Hochstrasser","year":"2020","unstructured":"Hochstrasser SR, Metzger K, Vincent AM, Becker C, Keller AKJ, Beck K, et al. Trimethylamine-N-oxide (TMAO) predicts short- and long-term mortality and poor neurological outcome in out-of-hospital cardiac arrest patients. Clin Chem Lab Med. 2020;59:393\u2013402. https:\/\/doi.org\/10.1515\/cclm-2020-0159.","journal-title":"Clin Chem Lab Med"},{"key":"1750_CR32","doi-asserted-by":"publisher","unstructured":"Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J Am Heart Assoc. 2017;6. https:\/\/doi.org\/10.1161\/jaha.116.004947","DOI":"10.1161\/jaha.116.004947"},{"key":"1750_CR33","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1080\/0886022x.2022.2131572","volume":"44","author":"C Hu","year":"2022","unstructured":"Hu C, Zhang Y, Bi X, Yao L, Zhou Y, Ding W. Correlation between serum trimethylamine-N-oxide concentration and protein energy wasting in patients on maintenance hemodialysis. Ren Fail. 2022;44:1669\u201376. https:\/\/doi.org\/10.1080\/0886022x.2022.2131572.","journal-title":"Ren Fail"},{"key":"1750_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-021-00581-5","volume":"9","author":"RH Chou","year":"2021","unstructured":"Chou RH, Wu PS, Wang SC, Wu CH, Lu SF, Lien RY, et al. Paradox of trimethylamine-N-oxide, the impact of malnutrition on microbiota-derived metabolites and septic patients. J Intensive Care. 2021;9:65. https:\/\/doi.org\/10.1186\/s40560-021-00581-5.","journal-title":"J Intensive Care"},{"key":"1750_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-022-01673-3","volume":"21","author":"X Xiong","year":"2022","unstructured":"Xiong X, Zhou J, Fu Q, Xu X, Wei S, Yang S, et al. The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy. Lipids Health Dis. 2022;21:60 https:\/\/doi.org\/10.1186\/s12944-022-01673-3.","journal-title":"Lipids Health Dis"},{"key":"1750_CR36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1053\/j.jrn.2022.11.001","volume":"33","author":"X Yuan","year":"2023","unstructured":"Yuan X, Wei X, Liu J, Tang C, Peng L, Wang H, et al. Association of circulating trimethylamine-N oxide with malnutrition and the risk of coronary artery disease in patients with maintenance hemodialysis. J Ren Nutr. 2023;33:465\u201371. https:\/\/doi.org\/10.1053\/j.jrn.2022.11.001.","journal-title":"J Ren Nutr"},{"key":"1750_CR37","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/ehf2.13290","volume":"8","author":"Y Kinugasa","year":"2021","unstructured":"Kinugasa Y, Nakamura K, Kamitani H, Hirai M, Yanagihara K, Kato M, et al. Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction. ESC Heart Fail. 2021;8:2103\u201310. https:\/\/doi.org\/10.1002\/ehf2.13290.","journal-title":"ESC Heart Fail"},{"key":"1750_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11883-021-00910-x","volume":"23","author":"MS Thomas","year":"2021","unstructured":"Thomas MS, Fernandez ML. Trimethylamine N-oxide (TMAO), diet and cardiovascular disease. Curr Atheroscler Rep. 2021;23:12. https:\/\/doi.org\/10.1007\/s11883-021-00910-x.","journal-title":"Curr Atheroscler Rep"},{"key":"1750_CR39","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/ajcn\/nqaa203","volume":"112","author":"A Crimarco","year":"2020","unstructured":"Crimarco A, Springfield S, Petlura C, Streaty T, Cunanan K, Lee J, et al. A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: study with appetizing plantfood-meat eating alternative trial (SWAP-MEAT). Am J Clin Nutr. 2020;112:1188\u201399. https:\/\/doi.org\/10.1093\/ajcn\/nqaa203.","journal-title":"Am J Clin Nutr"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41430-026-01750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-026-01750-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-026-01750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:54:44Z","timestamp":1783407284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41430-026-01750-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1038\/s41430-026-01750-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7387652\/v1","asserted-by":"object"}]},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: PS reports a relationship with Roche, Thermo Fisher, bioM\u00e9rieux, Nestl\u00e9 Health Science and Abbott Nutrition. that includes: funding grants. ZS reports a relationship with Nestl\u00e9 Health Science, Fresenius Kabi and B. Braun that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work the authors used OpenAI. (2024). ChatGPT (Version 4) to improve the writing and English language quality of their manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The Ethics Committee of Northwestern\/Central Switzerland (EKNZ; 2014_001) approved the study protocol. All participants or their authorized representatives provided written informed consent. The trial was registered at ClinicalTrials.gov (\n                      \n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}